BioServices

axway-will-help-sanofi-ensure-that-all-divisions-subsidiaries-and-new-acquisitions-are-able-to-efficiently-and-securely-exchange-and-manage-data-in-a-way-that-is-uniform-globally

Axway helps Sanofi to ‘fool-proof’ its IT infrastructure

  • Europe
  • |
  • News

Singapore: Sanofi joined hands with Axway in order to streamline processes and transform its technology infrastructure into an efficient global network. Axway will help the life science giant to make the transformation possible, enabling... Read more

ims-health-acquired-360-vantage-a-leading-provider-of-cloud-based-multi-channel-customer-relationship-management-crm-and-closed-loop-marketing-technologies

IMS Health acquires 360 Vantage


  • US
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: IMS Health has acquired 360 Vantage, a leading provider of cloud-based multi-channel customer relationship management... Read more

parexel-opens-its-6th-office-in-china-located-in-shenyang

Parexel opens its 6th office in China


  • China
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Parexel International opened a new office in Shenyang, China. This location will support growing client demand... Read more

dream-until-your-dreams-come-true-dr-shesheer-kumar-md-and-ceo-l-and-dr-rachna-tripathi-co-founder-and-director-r-ras-life-sciences

RAS: Our kits cost 8-fold less than that of MNC

  • India
  • |
  • Analysis
  • |
  • By Vipul Murarka
  • |
  • 0 Comment

Hyderabad-based RAS Life Sciences has in a span of six years achieved what many bootstrapped start-ups only aspire to. Competing with multinationals... Read more

frost-sullivan-report-european-healthcare-it-professional-services-market-earned-usd1

F&S: EU health IT services market to be $1.93 bn

  • Europe
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: New analysis from Frost & Sullivan titled, 'Analysis of the European Healthcare IT Professional Services Market', highlighted... Read more

parexel-acquires-liquent-for-usd72-million

Parexel acquires regulatory info firm Liquent

  • India
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Parexel International has acquired all of the outstanding equity securities of Liquent, a leading global provider of regulatory... Read more

logistics-are-the-backbone-of-pharma-and-biotech-infrastructure-and-need-to-be-efficient

Logistics demand attention as outsourcing picks up

  • Singapore
  • |
  • Analysis
  • |
  • By Amrita Tejasvi
  • |
  • 0 Comment

The European Medical Agency (EMA) recently raised concerns that since many sources of active substances for life-saving medicines are now... Read more

mr-herbert-vongpusanachai-managing-director-dhl-express-singapore

DHL MD: Poor logistics hinder drug shipments

  • Singapore
  • |
  • Influencers
  • |
  • By Amrita Tejasvi
  • |
  • 0 Comment

Mr Herbert Vongpusanachai has spent almost a decade managing Asian logistics market through DHL and has earned in-depth experience of the... Read more

mr-george-baeder-senior-vice-president-asia-pacific-consulting-and-china-commercial-quintiles-china

Mr George Baeder, Quintiles: Companies will fail to leverage on what China has to offer in 2013...

  • China
  • |
  • Opinion
  • |
  • By Mr George Baeder
  • |
  • 1 Comment

China's role in the global drug industry will fundamentally change; most companies will fail to capitalize on this opportunity. Prepare... Read more

mr-tarun-pandotra-project-manager-pra-india

Mr Tarun Pandotra, PRA India: Drug discovery outsourcing will gain momentum in 2013

  • India
  • |
  • Opinion
  • |
  • By Mr Tarun Pandotra
  • |
  • 0 Comment

The drug discovery outsourcing market will experience high revenue growth from 2013-to-2023. Expansion of the market will be stimulated... Read more

mr-denzil-benjamin-senior-director-clinical-trial-management-asia-pacific-icon-clinical-research-india

Mr Denzil Benjamin, ICON: New guidelines by India’s CDSCO will re-define the industry in 2013...

  • India
  • |
  • Opinion
  • |
  • By Mr Denzil Benjamin
  • |
  • 0 Comment

Adapting technology and tools to address the issues of increasing research and development (R&D) costs, slow results, lack of funding, regulatory... Read more

dr-anthony-s-rebuck-senior-consultant-head-of-strategic-drug-development-asia-quintiles-singapore

Dr Anthony S Rebuck, Quintiles: Entry of new biosimilars will transform biopharma in 2013

  • Singapore
  • |
  • Opinion
  • |
  • By Dr Anthony S Rebuck
  • |
  • 0 Comment

Big news in 2013 will be the growth of biosimilars in the biologics segment. By the end of the year, biosimilars will account for five percent... Read more

Special Features

Survey Box

Chinese Bird Flu H7N9

Have Chinese scientists done the right thing by fusing human and avian flu strains to create new killer viruses?

Send this article by email

X